US FDA approves Novartis Kesimpta (ofatumumab) for relapsing forms of MS treatment
Ofatumumab was first approved by the FDA in 2009 for the treatment of chronic lymphocytic leukaemia (CLL)
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
US FDA approval
Mylan announces launch of generic version of Biogen’s Tecfidera
Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS)
Aleor Dermaceuticals receives USFDA tentative approval for antifungal medication
Tavaborole topical solution, 5% is indicated for the treatment of onychomycosis of the toenails due to Trichophyton rubrum or…
Unichem gets US FDA approval for Tolterodine Tartrate tablets
These tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and…
GSK gets USFDA approval for BLENREP to treat relapsed or refractory multiple myeloma
BLENREP is the fifth major medicine approval for GSK in 2020
Biogen moves forward with potential Alzheimer’s drug, seeks US FDA’s approval
The drug, aducanumab, has had a tumultuous journey, with promising early data raising hopes and Biogen’s share price, only to be…
Aleor Dermaceuticals receives USFDA nod for scalp psoriasis product
Clobetasol Propionate Shampoo, 0.05%, has an estimated market size of $28 million for twelve months ending December 2019 according…
Aurobindo Pharma receives USFDA approval for Flucytosine Capsules
Flucytosine Capsules are indicated for the treatment of serious infections caused by susceptible strains of Candida and/or…
Zydus gets tentative USFDA approval for empagliflozin and metformin hydrochloride tablets
Zydus gets tentative USFDA approval for empagliflozin and metformin hydrochloride tablets
Glenmark gets tentative USFDA approval for generic anti-diabetes tablets
The approval is for the strength of 10 mg/5 mg tablets